2-235494699-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001037131.3(AGAP1):āc.13C>Gā(p.Gln5Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,383,698 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001037131.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AGAP1 | NM_001037131.3 | c.13C>G | p.Gln5Glu | missense_variant | 1/18 | ENST00000304032.13 | NP_001032208.1 | |
AGAP1 | NM_014914.5 | c.13C>G | p.Gln5Glu | missense_variant | 1/17 | NP_055729.2 | ||
AGAP1 | NM_001244888.2 | c.13C>G | p.Gln5Glu | missense_variant | 1/10 | NP_001231817.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AGAP1 | ENST00000304032.13 | c.13C>G | p.Gln5Glu | missense_variant | 1/18 | 5 | NM_001037131.3 | ENSP00000307634 |
Frequencies
GnomAD3 genomes Cov.: 29
GnomAD4 exome AF: 0.0000137 AC: 19AN: 1383698Hom.: 0 Cov.: 31 AF XY: 0.0000145 AC XY: 10AN XY: 688178
GnomAD4 genome Cov.: 29
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 27, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with AGAP1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glutamine, which is neutral and polar, with glutamic acid, which is acidic and polar, at codon 5 of the AGAP1 protein (p.Gln5Glu). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at